Announcement on Results of Shareholding Reduction by Director
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Henan Lingrui Pharmaceutical Co., Ltd. has announced the results of a shareholding reduction by a director. The director, Chen Yan, held a total of shares but did not execute any reduction during the specified period. The announcement confirms that the reduction plan was not implemented as planned, with no shares sold.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Henan Lingrui Pharmaceutial Co., Ltd. on 6ix
Earlier from Henan Lingrui Pharmaceutial
- Announcement on "Corporate Value and Return Enhancement" Action Plan
- Announcement on Resignation of Senior Management Member
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Canceling the Board of Supervisors and Amending the Articles of Association and Some Corporate Governance Systems
- Announcement on Shareholding Reduction Plan for Directors
Later from Henan Lingrui Pharmaceutial
- Announcement on the Pledge of Partial Shares by the Majority Shareholders
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Obtaining Drug Registration Certificate
- Announcement on the Release of Pledge of Partial Shares by Major Shareholders
- Announcement on Election of Employee Representative Directors for the 10th Board of Directors
Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.
Follow Henan Lingrui Pharmaceutial